Anyone else think Monil Shah renumeration is a bit rich..?
He gets $190K bonus for signing a pre clinical partnership for OnCARlytic's. That was it to meet his KPI.
Current T cell therapy can only go after blood cancers. I cant see the difficultly or "work" required to get a partner for mouse models on solid tumours. And correct me if I am wrong, but aren't we covering our own costs in this partnership?
Given his $595K static salary. In my opinion if he hasn't generated any revenue for the company he should not be inline to receive a bonus.
He's also paid in a fixed USD amount. If the Ozzie tumbles he'll end up getting more then Leslie at this rate.
Hate to think what his bonus would be if he actually signs a commercial deal.
Anyone else think Monil Shah renumeration is a bit rich..? He...
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
-0.003(4.84%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 6.1¢ | 6.3¢ | 5.8¢ | $2.926M | 48.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 1489666 | 5.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.9¢ | 1250588 | 5 |
View Market Depth
| Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
| IMU (ASX) Chart |